Richard Anziano

Richard Anziano has extensive experience in the field of statistics, particularly in the area of drug development. Richard worked as the Chief Statistician at Pharmetheus since March 2019. Prior to that, they operated their own statistical consulting business called Anziano Statistical Consulting, where they provided expertise in various aspects of drug development, such as US and EU Filings, quantitative decision making, business development, and organizational leadership. Richard also served as Pfizer's Vice President, Global Statistics Head, and Chief Statistician for 5 years, where they were responsible for leading a team of over 250 statisticians and overseeing a budget of 55M. In this role, they focused on driving the strategic direction for the group and establishing best practices for Data Monitoring Committees. Anziano has a strong background in therapeutic areas including Neuroscience, Cardiovascular, Inflammation, Infectious Disease, and Rare Disease.

Richard Anziano holds a Master of Science degree in Statistics from the University of Connecticut. Richard also attended Xavier High School, though no specific degree or field of study was mentioned.